Related Experiment Video
Updated: Feb 14, 2026

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
Published on: August 20, 2007
Cuproptosis and Diabetic Osteoporosis: Mechanisms and Therapeutic Prospects
Shih-Yu Chen1,2, Wanyi Chen3,4, Ze Gao1,3
1The First Affiliated Hospital of Jinan University, Guangzhou 510630, China.
Abstract:
Diabetic osteoporosis (DOP) is a metabolic bone disease characterized by abnormal bone tissue structure and reduced bone strength in patients with diabetes. Its pathogenesis is complex, involving multiple factors rather than a single cause, and has not yet been fully elucidated. Cuproptosis, a novel form of programmed cell death discovered in 2022, differs mechanistically from apoptosis, necroptosis, and ferroptosis. This process relies on the accumulation of intracellular copper ions and is closely associated with mitochondrial respiration. Studies have indicated that cuproptosis is intimately linked to glucose metabolism and bone metabolism. This review explores the role of copper homeostasis in maintaining glucose metabolism and bone quality and systematically elucidates the potential associations between cuproptosis and these processes from molecular, cellular, and pathophysiological perspectives, aiming to provide new insights and prospects for future research directions in diabetic osteoporosis.
Insights
Diabetic osteoporosis involves complex factors. This review explores how cuproptosis, a copper-dependent cell death, may link to diabetes and bone health, offering new research avenues.
Area of Science:
- Biochemistry
- Cell Biology
- Metabolic Diseases
Background:
- Diabetic osteoporosis (DOP) is a complex metabolic bone disease linked to diabetes.
- Its exact pathogenesis remains unclear, involving multiple contributing factors.
- Cuproptosis, a recently discovered cell death pathway, is linked to copper ion accumulation and mitochondrial respiration.
Purpose of the Study:
- To explore the role of copper homeostasis in glucose and bone metabolism.
- To elucidate the potential associations between cuproptosis and diabetic osteoporosis.
- To provide novel insights for future research in DOP.
Main Methods:
- Literature review focusing on molecular, cellular, and pathophysiological mechanisms.
- Analysis of existing studies on copper metabolism, glucose regulation, and bone health.
- Synthesis of information linking cuproptosis to diabetic osteoporosis.
Main Results:
- Cuproptosis is mechanistically distinct from other cell death types.
- Evidence suggests a link between copper homeostasis, glucose metabolism, and bone quality.
- Cuproptosis may play a role in the development of diabetic osteoporosis.
Conclusions:
- Copper homeostasis is crucial for maintaining glucose and bone metabolism.
- Cuproptosis presents a potential new pathway involved in diabetic osteoporosis.
- Further research into cuproptosis could offer novel therapeutic targets for DOP.
Related Concept Videos
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Therapeutic Index
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Psychoneuroimmunology: Diabetes and Cancer
Therapeutic Communication
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...

